DeDora Capital’s Quest Diagnostics DGX Stock Holding History

DeDora Capital’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-129	Closed	-$18K	–	180
2022 Q1	$18K	Buy	+129	New	+$18K	0.01%	245

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

DeDora Capital's DGX Position: Q2 2022 in Review

DeDora Capital sold out of Quest Diagnostics (DGX) in Q2 2022, closing a stake of 129 shares — an estimated $18K sold.

DeDora Capital first reported a position in DGX in Q1 2022 and held it in 1 quarter. The position peaked at $18K in Q1 2022. 851 funds tracked by Wall St. Rank hold DGX as of Q2 2022.

DeDora Capital reported no remaining Quest Diagnostics position as of Q2 2022 after selling out during the quarter.
DeDora Capital sold 129 Quest Diagnostics shares in Q2 2022, an estimated $18K.
DeDora Capital first reported a position in Quest Diagnostics in Q1 2022 and held it in 1 quarter.
DeDora Capital's Quest Diagnostics position peaked at $18K in Q1 2022.
851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.

Based on DeDora Capital's 13F filing for Q2 2022, filed 27 Jul 2022.